STOCK TITAN

Portage Biotech Inc SEC Filings

PRTG NASDAQ

Welcome to our dedicated page for Portage Biotech SEC filings (Ticker: PRTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

PRTG filings document a foreign-private-issuer record that later appears under AlphaTON Capital Corp and Alpha Compute Corp, with disclosures covering corporate-status changes, Nasdaq listing matters, capital raising and governance. Form 6-K reports describe amendments to the issuer's British Virgin Islands memorandum and articles, a corporate name change, registration-statement incorporation and related trading-symbol changes.

The filing record also includes Nasdaq minimum-bid-price correspondence, board composition changes and an at-the-market ordinary share offering conducted under a Form F-3 shelf registration statement. These filings frame the issuer's capital structure, charter documents, exchange compliance and public-company reporting status.

Rhea-AI Summary

Alpha Compute Corp reports a major shift toward revenue-generating GPU infrastructure in mid‑Q2 2026. The company secured a $32.2 million, two-year contract, equal to $16.1 million in annual contracted revenue, up sharply from about $30,000 as of Q1 2026.

Alpha Compute projects $21 million in revenue over the next 12 months, combining contracted revenue and expected contribution from the pending GAMEE acquisition, and cites a $200 million-plus qualified sales pipeline. Its ALPHA-01 Canadian cluster with 504 NVIDIA B200 GPUs is live, while the Swedish ALPHA-02 build targets Q3 2026 with a projected 576 GPUs, both powered by hydroelectric energy.

As of May 21, 2026, the company reports $10.2 million in cash and cash equivalents, $66.9 million in total assets, and debt comprising $26.6m GPU lease liability and $328k in TON coin‑collateralized debt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Alpha Compute Corp reports a major shift toward revenue-generating GPU infrastructure in mid‑Q2 2026. The company secured a $32.2 million, two-year contract, equal to $16.1 million in annual contracted revenue, up sharply from about $30,000 as of Q1 2026.

Alpha Compute projects $21 million in revenue over the next 12 months, combining contracted revenue and expected contribution from the pending GAMEE acquisition, and cites a $200 million-plus qualified sales pipeline. Its ALPHA-01 Canadian cluster with 504 NVIDIA B200 GPUs is live, while the Swedish ALPHA-02 build targets Q3 2026 with a projected 576 GPUs, both powered by hydroelectric energy.

As of May 21, 2026, the company reports $10.2 million in cash and cash equivalents, $66.9 million in total assets, and debt comprising $26.6m GPU lease liability and $328k in TON coin‑collateralized debt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Alpha Compute Corp has closed a two-year compute off-take agreement with a leading frontier AI research lab, with a total contract value of $32.2 million. The deal, covering a dedicated cluster of 504 NVIDIA B200 GPUs in a Canadian data center powered by 100% hydroelectric energy, is expected to generate $16.1 million in Annual Recurring Revenue and includes an anticipated $7.5 million upfront payment to reserve capacity. Executives describe this as the Company’s first enterprise-scale B200 deployment and a critical step in its commercial strategy for AI GPU-as-a-service and confidential compute.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Alpha Compute Corp has closed a two-year compute off-take agreement with a leading frontier AI research lab, with a total contract value of $32.2 million. The deal, covering a dedicated cluster of 504 NVIDIA B200 GPUs in a Canadian data center powered by 100% hydroelectric energy, is expected to generate $16.1 million in Annual Recurring Revenue and includes an anticipated $7.5 million upfront payment to reserve capacity. Executives describe this as the Company’s first enterprise-scale B200 deployment and a critical step in its commercial strategy for AI GPU-as-a-service and confidential compute.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AlphaTON Capital Corp has changed its corporate name to Alpha Compute Corp after filing a Certificate of Change of Name and amended Memorandum and Articles of Association on April 14, 2026. The company states the new name better reflects its expanded operations in compute and AI infrastructure.

From April 21, 2026, its common shares will trade on the Nasdaq Capital Market under the new symbol ALP. The amended constitutional documents are attached as exhibits and set out the company’s BVI company law framework, including an unlimited number of no‑par‑value ordinary shares and detailed governance provisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AlphaTON Capital Corp has changed its corporate name to Alpha Compute Corp after filing a Certificate of Change of Name and amended Memorandum and Articles of Association on April 14, 2026. The company states the new name better reflects its expanded operations in compute and AI infrastructure.

From April 21, 2026, its common shares will trade on the Nasdaq Capital Market under the new symbol ALP. The amended constitutional documents are attached as exhibits and set out the company’s BVI company law framework, including an unlimited number of no‑par‑value ordinary shares and detailed governance provisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

AlphaTON Capital Corp director and Chief Executive Officer Kaiser Brittany has filed an initial insider ownership report on Form 3. This filing establishes her status as a reporting person but, in the provided data, shows no reported transactions or specific share holdings at this time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp director and Chief Executive Officer Kaiser Brittany has filed an initial insider ownership report on Form 3. This filing establishes her status as a reporting person but, in the provided data, shows no reported transactions or specific share holdings at this time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp director Michael Terpin filed an initial Form 3, which is a required statement of beneficial ownership when someone becomes an insider such as a director. The filing does not list any stock transactions or current holdings for Terpin, serving only as an initial registration of his insider status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AlphaTON Capital Corp director Michael Terpin filed an initial Form 3, which is a required statement of beneficial ownership when someone becomes an insider such as a director. The filing does not list any stock transactions or current holdings for Terpin, serving only as an initial registration of his insider status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp director and Chief Investment Officer Villani Fiorenzo filed an initial ownership report on Ordinary Shares. The filing shows direct ownership of 143,000 Ordinary Shares and an additional 100,831 Ordinary Shares held indirectly by Alpha Sigma Capital Advisors, LLC.

The footnote explains these indirectly held shares are owned by Alpha Sigma Capital Advisors, LLC, where Fiorenzo is Executive Director, and that he disclaims beneficial ownership of those securities. This Form 3 does not report any new purchases or sales, only the existing share positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp director and Chief Investment Officer Villani Fiorenzo filed an initial ownership report on Ordinary Shares. The filing shows direct ownership of 143,000 Ordinary Shares and an additional 100,831 Ordinary Shares held indirectly by Alpha Sigma Capital Advisors, LLC.

The footnote explains these indirectly held shares are owned by Alpha Sigma Capital Advisors, LLC, where Fiorenzo is Executive Director, and that he disclaims beneficial ownership of those securities. This Form 3 does not report any new purchases or sales, only the existing share positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AlphaTON Capital Corp filed an initial ownership report for Chief Financial Officer Wesley Allen Levitt. This Form 3 establishes his status as an insider for regulatory reporting purposes. The filing does not list any share transactions or existing derivative positions in the disclosed data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp filed an initial ownership report for Chief Financial Officer Wesley Allen Levitt. This Form 3 establishes his status as an insider for regulatory reporting purposes. The filing does not list any share transactions or existing derivative positions in the disclosed data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AlphaTON Capital Corp has received a notice from the Nasdaq Listing Qualifications Department stating that its common stock no longer meets the Nasdaq Capital Market’s minimum bid price requirement of $1.00 per share, after trading below this level for 30 consecutive business days.

The company has a 180-day compliance period, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. If it qualifies, AlphaTON may receive an additional 180 days; otherwise, its shares could become subject to delisting, with the option to appeal to a Nasdaq Hearings Panel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

AlphaTON Capital Corp has received a notice from the Nasdaq Listing Qualifications Department stating that its common stock no longer meets the Nasdaq Capital Market’s minimum bid price requirement of $1.00 per share, after trading below this level for 30 consecutive business days.

The company has a 180-day compliance period, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. If it qualifies, AlphaTON may receive an additional 180 days; otherwise, its shares could become subject to delisting, with the option to appeal to a Nasdaq Hearings Panel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AlphaTON Capital Corp established an at-the-market share offering program allowing it to sell up to $400,000,000 of its ordinary shares through H.C. Wainwright & Co. as sales agent or principal. Sales will be made under an effective Form F-3 shelf and a new prospectus supplement, with commissions of up to 3.0% of gross proceeds.

The company plans to use any net proceeds to fund capital spending for development, training and operation of its Cocoon AI platform, including servers, GPUs and related infrastructure, to pursue complementary acquisitions or investments, and for working capital and other general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

AlphaTON Capital Corp established an at-the-market share offering program allowing it to sell up to $400,000,000 of its ordinary shares through H.C. Wainwright & Co. as sales agent or principal. Sales will be made under an effective Form F-3 shelf and a new prospectus supplement, with commissions of up to 3.0% of gross proceeds.

The company plans to use any net proceeds to fund capital spending for development, training and operation of its Cocoon AI platform, including servers, GPUs and related infrastructure, to pursue complementary acquisitions or investments, and for working capital and other general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

AlphaTON Capital Corp is launching an at-the-market equity program to sell up to $400,000,000 of ordinary shares through H.C. Wainwright as sales agent or principal. Shares may be sold from time to time on Nasdaq under the symbol ATON or through other permitted methods at prevailing market prices.

The company plans to use net proceeds mainly to fund capital expenditures for Cocoon AI, including servers, GPUs and related infrastructure, and to pursue strategic acquisitions or investments aligned with the Telegram and TON ecosystem, with any remainder for working capital and general corporate purposes.

As context, AlphaTON reports 23,434,588 ordinary shares outstanding as of February 13, 2026, so issuing a large portion of the program would significantly increase the share count and dilute existing holders. Wainwright will receive up to a 3.0% sales commission on gross proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

AlphaTON Capital Corp is launching an at-the-market equity program to sell up to $400,000,000 of ordinary shares through H.C. Wainwright as sales agent or principal. Shares may be sold from time to time on Nasdaq under the symbol ATON or through other permitted methods at prevailing market prices.

The company plans to use net proceeds mainly to fund capital expenditures for Cocoon AI, including servers, GPUs and related infrastructure, and to pursue strategic acquisitions or investments aligned with the Telegram and TON ecosystem, with any remainder for working capital and general corporate purposes.

As context, AlphaTON reports 23,434,588 ordinary shares outstanding as of February 13, 2026, so issuing a large portion of the program would significantly increase the share count and dilute existing holders. Wainwright will receive up to a 3.0% sales commission on gross proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Portage Biotech (PRTG) SEC filings are available on StockTitan?

StockTitan tracks 39 SEC filings for Portage Biotech (PRTG), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Portage Biotech (PRTG)?

The most recent SEC filing for Portage Biotech (PRTG) was filed on May 21, 2026.